Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Science Advances
|
September 10, 2025
Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells
Kelly McCastlain, Catherine Welsh, Yonghui Ni, et al.
Leukemia
|
August 24, 2019
MYC dysregulation in the progression of multiple myeloma
Kristine Misund, Niamh Keane, Caleb K Stein, et al.
Blood Cancer Journal
|
October 31, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Alejandro Medina, Noemi Puig, Juan Flores-Montero, et al.
American Journal of Hematology
|
November 16, 2024
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy
Aintzane Zabaleta, Noemi Puig, Maria-Teresa Cedena, et al.
Blood
|
May 22, 2025
Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment
Marta Lasa, Carmen Gonzalez, Laura Notarfranchi, et al.
Nature
|
March 1, 2018
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Xiaotu Ma, Yu Liu, Yanling Liu, et al.
Blood Advances
|
March 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study
Irene Dogliotti, Cristina Jiménez, Veronica Peri, et al.
Blood Neoplasia
|
April 24, 2026
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma
Lorea Jordana-Urriza, Guillermo Serrano, Sergio Camara-Peña, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Science Advances
|
September 10, 2025
Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells
Kelly McCastlain, Catherine Welsh, Yonghui Ni, et al.
Leukemia
|
August 24, 2019
MYC dysregulation in the progression of multiple myeloma
Kristine Misund, Niamh Keane, Caleb K Stein, et al.
Blood Cancer Journal
|
October 31, 2020
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Alejandro Medina, Noemi Puig, Juan Flores-Montero, et al.
American Journal of Hematology
|
November 16, 2024
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy
Aintzane Zabaleta, Noemi Puig, Maria-Teresa Cedena, et al.
Blood
|
May 22, 2025
Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment
Marta Lasa, Carmen Gonzalez, Laura Notarfranchi, et al.
Nature
|
March 1, 2018
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Xiaotu Ma, Yu Liu, Yanling Liu, et al.
Blood Advances
|
March 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study
Irene Dogliotti, Cristina Jiménez, Veronica Peri, et al.
Blood Neoplasia
|
April 24, 2026
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma
Lorea Jordana-Urriza, Guillermo Serrano, Sergio Camara-Peña, et al.
Page
of 10